Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide/formoterol inhalation powder (II) for adult asthma
CTR20260268Phase 3Active
- Sponsor
- Shandong Jianwei Pharmaceutical
- Start
- Mar 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide + formoterol in asthma, sponsored by Shandong Jianwei Pharmaceutical. Started Mar 2026; status: active.
02
Drugs
budesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20260268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260268.